Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Sponsor: InduPro, Inc.
Summary
This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).
Official title: A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
132
Start Date
2026-07-08
Completion Date
2028-12
Last Updated
2026-09-03
Healthy Volunteers
No
Conditions
Interventions
IDP-001
IV infusion
Locations (6)
START Los Angeles
Los Angeles, California, United States
Florida Cancer Specialists
Sarasota, Florida, United States
Community Cancer Center North
Indianapolis, Indiana, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
START New York Long Island
Lake Success, New York, United States
START Dallas Forth Worth
Fort Worth, Texas, United States